Skip to content

Clinical trials

Withdrawn Biliary Tract Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Neoplasms Status: Withdrawn Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20151
20181
20193
20203
20212
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
ASLAN Pharmaceuticals1
Ambrx, Inc.1
Georgetown University1
Institut Bergonié1
Jiangsu HengRui Medicine Co., Ltd.1
Jordan Kharofa1
Karolinska Institutet1
Karus Therapeutics Limited1
New Mexico Cancer Research Alliance1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Neoplasms15
Carcinoma, Non-Small-Cell Lung2
Cholangiocarcinoma2
Gallbladder Neoplasms2
Bites and Stings1
Breast Neoplasms1
Colorectal Neoplasms1
Duodenal Neoplasms1
Esophageal Neoplasms1
Jaundice1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.